ASX:COHCochlear Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$182.02 -7.98 (-4.20 %) (As of 04/5/2020 02:44 PM ET) Add Compare Share Today's RangeA$178.29Now: A$182.02▼A$195.2750-Day RangeA$157.81MA: A$205.05▼A$247.9052-Week RangeA$154.60Now: A$182.02▼A$254.40Volume445,282 shsAverage Volume194,422 shsMarket Capitalization$10.53 billionP/E Ratio34.38Dividend Yield1.94%BetaN/A ProfileAnalyst RatingsAdvanced ChartDividendEarningsInsider TradesHeadlinesOptions Chain Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaborations with Sensorion and GN Hearing A/S to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cochlear. Previous Next 2.0 Community Rank Outperform VotesCochlear has received 163 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCochlear has received 250 “underperform” votes. (Add your “underperform” vote.)Community SentimentCochlear has received 60.53% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote “Outperform” if you believe COH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipCochlear is a leading dividend payer. It pays a dividend yield of 1.94%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthCochlear does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Cochlear is 63.28 %. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cochlear insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Cochlear are expected to decrease by -100.00% in the coming year, from A$4.98 to A$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cochlear is 34.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 10.45.Price to Earnings Ratio vs. SectorThe P/E ratio of Cochlear is 34.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 13.82.Price to Book Value per Share RatioCochlear has a P/B Ratio of 13.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.90 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:COH Previous Symbol CUSIPN/A CIKN/A Webhttp://www.cochlear.com/ Phone+61-2-94286555Debt Debt-to-Equity Ratio52.41 Current Ratio1.87 Quick Ratio1.18Price-To-Earnings Trailing P/E Ratio34.38 Forward P/E Ratio36.55 P/E GrowthN/A Sales & Book Value Annual Sales$1.48 billion Price / Sales7.12 Cash FlowA$1.48 per share Price / Cash Flow122.82 Book ValueA$13.95 per share Price / Book13.05Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees3,500 Outstanding Shares57,829,900Market Cap$10.53 billion Next Earnings DateN/A OptionableOptionable Receive COH News and Ratings via Email Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter. Cochlear (ASX:COH) Frequently Asked Questions How has Cochlear's stock been impacted by COVID-19 (Coronavirus)? Cochlear's stock was trading at A$189.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, COH shares have decreased by 3.7% and is now trading at A$182.02. View which stocks have been mosted impacted by Coronavirus. How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) released its earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share for the quarter, missing the Zacks' consensus estimate of $2.19 by $0.04. View Cochlear's earnings history. How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear announced a Interim dividend on Wednesday, February 19th. Stockholders of record on Friday, April 17th will be given a dividend of 1.60 per share on Friday, April 17th. This represents a yield of 0.64%. The ex-dividend date is Tuesday, March 24th. This is an increase from Cochlear's previous Interim dividend of $1.55. View Cochlear's dividend history. Has Cochlear been receiving favorable news coverage? Press coverage about COH stock has been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cochlear earned a news impact score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutCochlear. Who are some of Cochlear's key competitors? Some companies that are related to Cochlear include Fisher & Paykel Healthcare (FPH), ConvaTec Group (CTEC), Avita Medical (AVH), Stratec (SBS), Draegerwerk AG & Co KGaA (DRW3), Zynex (ZYXI), Creo Medical Group (CREO), Hamilton Thorne (HTL), Medica Group (MGP), Cyclopharm (CYC), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Electromed (ELMD), Electromed (ELMD), Somnomed (SOM) and REVA Medical (RVA). What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), ResMed (RMD), CSL (CSL), Alumina (AWC), Nufarm (NUF), REA Group (REA), TPG Telecom (TPM), Janus Henderson Group (HGG), Mesoblast (MESO) and Omnicell (OMCL). Who are Cochlear's key executives? Cochlear's management team includes the following people: Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 52)Mr. Brent Andrew Cubis, Chief Financial OfficerMr. Jan Janssen, Chief Technology OfficerMr. Richard Brook, Pres of EMEA & Latin American RegionMr. Anthony Manna, Pres of Americas Region What is Cochlear's stock symbol? Cochlear trades on the ASX under the ticker symbol "COH." What is Cochlear's stock price today? One share of COH stock can currently be purchased for approximately A$182.02. How big of a company is Cochlear? Cochlear has a market capitalization of $10.53 billion and generates $1.48 billion in revenue each year. Cochlear employs 3,500 workers across the globe. View additional information about Cochlear. What is Cochlear's official website? The official website for Cochlear is http://www.cochlear.com/. How can I contact Cochlear? Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555. This page was last updated on 4/5/2020 by MarketBeat.com StaffFeatured Article: What economic reports are most valuable to investors?
